What is oral phynylephrine and why does the FDA want to remove it from cold medicine?
Oral phenylephrine is used in over-the-counter products like Sudafed and Dayquil to help temporarily relieve the common ...
Medscape3d
Healthcare: What Could Change Under New Trump Administration?
The Affordable Care Act may not be dismantled, but Americans could see lower subsidies, experts say. Other changes may be in ...
How tech leaders tied to Musk hope to steer the Trump administration
In Elon Musk’s Trump-world ascension, tech leaders on the right see an opportunity to enact radical change and bring a ...
The Washington Post on MSN2d
State votes on marijuana and psychedelics signal drug policy concerns
The ballot decisions Tuesday point to voter concerns that drug policies have drifted too far to the left, according to policy ...
Drugmaker shut down after black schmutz found in injectable weight-loss drug
The FDA became aware of the problem after a patient submitted a complaint to the regulator that a vial of semaglutide from ...
Men's Journal on MSN3d
FDA Recommends Removing Ingredient From Many Cold and Allergy Medicines After Research Shows It Doesn't Work
Cold and flu season is upon us and Americans will be flocking to pharmacy shelves to pick up some medicine to alleviate their ...
Novo Nordisk aware of reports 10 people taking compounded weight-loss drug copies died
Novo Nordisk chief financial officer Karsten Munk Knudsen said on Wednesday the company was aware of reports of 10 deaths and ...
Robert F. Kennedy Jr.’s Views Now Matter for the Nation. Here’s How He Could Influence Food and Drug Policy
Robert F. Kennedy Jr is known as a persistent critic of vaccine safety and is a longtime antagonist of the Food and Drug ...
Unicycive: FDA to Review Lead Drug Candidate for Hyperphosphatemia
Unicycive, which is seeking an FDA green light for oxylanthanum carbonate to treat hyperphosphatemia in patients with chronic kidney disease who are on dialysis, Monday said the agency set a target ...
Verywell Health on MSN2d
GLP-1 Drug Shortage Is Over. Why Might These Drugs Soon Be Costlier and Harder to Access?
The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move ...
The Associated Press on MSN10d
A promising schizophrenia drug showed mixed results. What does that mean for patients?
Some people who took a new schizophrenia drug for one year improved with only a few side effects, but many dropped out of the ...